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Effect of a French Experiment of Team Work between General Practitioners and 
Nurses on Efficacy and Cost of Type 2 Diabetes Patients Care 
Julien Mousquès
a,b*, Yann Bourgueil








This study aims to assess the efficacy and the cost of a French team work experiment between nurses 
and GPs for the managing of type 2 diabetes patients. Our study was based on a case control study 
design in which we compare the evolution of process (standard follow-up procedures) and final 
outcomes (glycemic control), and the evolution of cost. The study is realized for two consecutive 
periods between type 2 diabetes patients followed within the team work experiment (intervention 
group) or by “standard” GPs (controlled group). 
After 11 months of follow-up, we showed that patients in the intervention group, compared with those 
in the controlled group, have more chances to remain or to become: correctly followed-up (with OR 
comprise between 2.1 to 6.8, p<=5%) and under glycemic control (with OR comprise between 1.8 to 
2.7, p<=5%). The latter result is obtained only when a visit for education and counselling has been 
delivered by a nurse in supplement to systematic electronic patient registry and electronic clinical GPs 
reminder. All these results are obtained without difference in costs between the intervention and the 
controlled groups. 
Finally, this experimentation of team working can be considered both effective and efficient. Our 
findings may have implications in the design of future larger primary care team work experiments to be 
launched by French health authorities. 
Keywords: Primary health care, Diabetes mellitus, Health care team, Comparative study, Outcome 
and process assessment, Cost analysis. 
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Résumé 
Cette étude a pour objectif d’évaluer l'efficacité et les coûts d'une expérimentation de travail en équipe 
entre des infirmières et des généralistes (l’expérimentation Action Santé Libérale En Equipe 
(ASALEE)), dans le cas de la prise en charge des patients souffrant de diabète de type 2. 
Elle s’appuie sur un design cas/témoin dans lequel nous comparons l'évolution des résultats de soins 
en termes de processus  (procédures standards de suivi) et de résultat final (le contrôle glycémique), 
ainsi qu’en termes de coûts. Cette comparaison est réalisée entre deux périodes consécutives et entre 
des patients diabétiques de type 2 suivis dans l'expérimentation (le groupe d'intervention) ou dans le 
groupe témoin (le groupe contrôle). 
Nous montrons qu'après onze mois de suivi, les patients ASALEE, comparés à ceux du groupe 
témoin, ont une plus grande probabilité de rester ou devenir bien suivis en termes d’indicateurs de 
processus (OR compris entre 2.1 à 6.8, p < 5 %), ainsi qu’en termes de contrôle glycémique (OR 
compris entre 1.8 à 2.7, p < 5 %). Ces derniers résultats sont obtenus uniquement lorsque les patients 
ont bénéficié d’au moins une consultation infirmière d’éducation et de conseils hygiéno-diététiques en 
complément du rôle classique des infirmières dans le cadre de l’expérimentation ASALEE, c’est-à-dire 
la mise à jour des dossiers médicaux informatisés avec l’inscription éventuelle de rappels 
informatiques à destination des généralistes. 
Mots-clefs : soins primaires, diabète de type 2, travail en équipe, étude comparative, évaluation des 
résultats et des processus, analyse de coût. 
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1. Introduction 
The improvement of the quality of care delivered by health professionals and the strengthening of 
primary care organization are seen as two key elements for increasing the performance of health care 
systems in a context of increasing demand and constraints in resources [1-6]. Thus, numerous 
countries have undertaken reforms that aim at improving medical practices or organizing in a different 
way the provision of primary or ambulatory care and services, especially for chronic patients. This 
requires the production of medical practice guidelines and the implementation of “evidence based 
medicine” in daily practice through policy intervention close to doctors and the implementation of 
primary care and services organisational innovations: chronic care and/or disease management, 
performance based economic incentives, group practice and team work [7]. 
Numerous systematic literature reviews are henceforth available [8-15]. Passive intervention policy, 
which includes the simple provision of educational material and standard education activities (e.g. 
conferences, congresses,...) are considered to be little effective. On the contrary, more active policy 
interventions have proved to be more effective. These include more advanced continuing medical 
education strategies (e.g. academic detailing); therapeutic information systems, audit and feedback 
as well as electronic reminders; and finally, all “organisational-oriented” policies. Within the latter, our 
concern is specifically about policies focused on teamwork and cooperation between GPs and nurses, 
when nurses substitute or supplement physician workforce. Most of the studies converge in their 
conclusions: nurses adequately trained for specific actions (e.g. prevention, first contact, follow-up of 
a chronic patient…) can deliver care and services at least from a same level of outcome in terms of 
quality – indeed superior when the nurse act in complement – and with a greater level of outcome in 
terms of satisfaction, than of primary care doctors [10,16,17]. The magnitude of cost saving and of 
efficiency gains depends on salary and productivity differentials between nurses and GPs, and 
possible duplication. 
In France, in spite of a public debate on the levers for performance improvement at the professional 
or organisational levels [18-22], the recent reforms conserve an “embryonic character”. Our health 
system still combines a relative free and comprehensive access to care and services for insured 
[23,24], with a weak regulation both of professional practices and ambulatory care organisations. One 
can observe that the French health care system has a fragmented ambulatory care system, more 
than a formal primary care organisation. Most of ambulatory care professionals are self-employed and 
work in solo practice paid on a fee-for-service basis. They are historically not subject to constraint by 
any strict mandatory quality regulation, and only recently both continuing medical education and the 
evaluation of professional practice have become mandatory. 
As a consequence, several signs of inefficiency in health care delivery have come to light; especially 
for chronically ill patients for whom there has been no dramatic improvement in the care delivery – 
e.g. for diabetes patients [25-29] – despite their growing place in the burden of disease and the fact 
that they currently consume an increasing share of the French health care system’s resources 
[30,31]. 
After all, some experiments of networks, GP group practices, skill mix and teamwork (e.g. between 
GPs and nurses), are supported by an increasing number of stakeholders (sickness funds, state and 
local representatives…) and professionals’ representatives [32, 33]. A national policy experiment in 
cooperation and skill mix was carried out between 2004 and 2008 [33,34]. This policy authorized ten 
experiments which involved mainly the transfer of: technical procedures, follow-up of chronic patients 
with hepatitis, prevention. Only two of them are related to ambulatory care, and one to general 
practice: the ASALEE experiment (Action de Santé Libérale en Equipe
1). 
Our general objective is to assess the efficacy and the cost of the ASALEE experiment regarding the 
management of type 2 diabetes patients, defined by the fact that they are treated by at least one oral 
anti-diabetic medication, which represents the bulk of the nurse working time
2. The ASALEE 
experiment began in 2004 with 3 practices clustering 12 GPs and 3 nurses. In 2007, 18 practices 
                                                      
1   Health Action by Teams of Self-employed Health Professionals. 
 
2   Nurses are also involve in: counseling for high blood pressure, screening for cognitive problems and cardiovascular 
risk factors in individuals over 75 years old, screening campaigns (breast cancer, cervix cancer,  cognitive disorder).  
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involving 41 GPs and 8 nurses participated in the experiment. All the GPs and nurses remained in the 
experiment from the beginning. 
Our specific objectives are: first, to assess the efficacy both regarding process (adequacy of follow-up 
procedures) and final (glycemic control) outcomes; second, to assess the difference of impact 
between two levels of nurse intervention in supplement to the GP: systematic electronic patient 
registry and electronic clinical reminder (level 1) combine or not with patient education and 
counselling (level 2); third, to assess the impact on direct costs for the National Health Insurance 
Funds, including additional cost generated by ASALEE experiment (i.e. nurses’ wages,...). 
 
2. Materials  and  methods 
 
For type 2 diabetes patients, the activity provided by the nurses complements the GPs’ at two levels. 
The first level (level 1) of intervention by the nurses is a systematic electronic patient registry of type 2 
diabetes patients. This list was based on of the GPs’ electronic patient records. For all these patients, 
the nurses log specific information (mainly requested biological results for the follow up). If require, 
the nurses can introduce electronic reminders inside electronic patient records. These electronic 
reminders alert the GP, during the patient’s visit, the examinations to be conducted according to the 
national guidelines. The second level of intervention (level 2) is patient education and counselling in 
order to give nutritional-hygienic and treatment compliance advices. They are performed by nurses 
after a referral from the GP and are conditioned by an agreement from the patient. 
Our evaluation design was constituted by three distinctive case control studies which compare the 
evolution of three dimensions of results between two consecutive periods between the intervention 
(ASALEE experiment) and the controlled groups (IGs vs. CGs). For the latter no nurses’ assistance in 
their practice was developed. The three domains assessed were: efficacy regarding process 
outcomes, efficacy regarding final outcome, costs. Then, IGs cases were based on three subsamples 
of type 2 diabetes patients followed by GPs and nurses of the ASALEE experiment – depending on 
the level of nurses intervention they had benefitted – between June 2004 and May 2007 and still 
followed in May 2007 (intention to treat study). These three IG subsamples were compared, a 
posteriori, with those of three CGs. It should be noted that controlled group samples was matched to 
intervention group samples at baseline, with at least an equivalent distribution in terms of age and 
gender. Table 1 gives the distribution of all the variables for IGs compared with the distribution in the 
CGs; we could observe that characteristics of type 2 diabetes patients in the IGs and in the CGs are 
similar.  
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Woman 704 41.81 254 43.2 362 43.2 347 43.65
Men 980 58.19 334 56.8 476 56.8 448 56.35
Age*
< 50 years 129 7.66 22 3.74 72 8.59 63 7.92
50-60 years 315 18.71 103 17.52 172 20.53 166 20.88
60-70 years 438 26.01 148 25.17 218 26.01 203 25.53
70-80 years 552 32.78 202 34.35 286 34.13 274 34.47
>= 80 years 250 14.85 113 19.22 90 10.74 89 11.19
Age*
< 65 years 659 39.13 198 33.67 - -
>= 65 years 1 025 60.87 390 66.33 - -
Type of follow-up by Public Health Nurse since 
Data management (+/- electronic reminder) 987 58.61 304 51.7 435 51.91 409 51.45
Data management (+/-electronic reminder) and 
visit for education and counselling 
697 41.39 284 48.3 403 48.09 386 48.55
Location within the Deux-Sèvres department 
North - - - - 229 27.33 218 27.42
South - - - - 609 72.67 577 72.58
Type of Mandatory Social Security Funds
National Health Insurance Fund for salaried 
salaried employees
- - - - 611 72.91 572 71.95
National Health Insurance Fund for farmers 
workers
- - - - 227 27.09 223 28.05
Waves of inclusion (in 4 classes)**
June 2004 to March 2005 348 20.67 - - 188 22.43 185 23.27
April 2005 to January 2006 255 15.14 - - 122 14.56 115 14.47
February 2006 to June 2006 302 17.93 - - 146 17.42 139 17.48
July 2006 to May 2007 779 46.26 - - 382 45.58 356 44.78
Waves of inclusion  (in 3 classes)**
June to December 2004 - - 184 31.29 - - - -
February to July 2005 - - 171 29.08 - - - -
January to June 2006 - - 233 39.63 - - - -
Total 1 684 100 588 100 838 100 795 100
Cost
Study population regarding the nature of the assessment




Efficacy according to 





* Due to technical consideration number of age classes were dependent on the nature of assessment 
** Due to technical consideration number of waves classes were dependent on the nature of assessment 
 
 
The first efficacy evaluation was based on the analysis of the evolution between two consecutive 
periods – between July 2005-June 2006 (t-1) and between July 2006-June 2007 (t) –, of process 
outcome measures, which corresponds to the probabilities of becoming or still be adequately 
followed-up, over one year, for six standard follow-up procedures recommended by the French 
National Authority in Health guidelines. According to these guidelines, the rate of HbA1c of patients 
suffering from diabetes must be controlled at least three times a year and they must also be subjected 
to a biological examination every year (creatinemia, microalbuminuria, lipid check-up), to an 
electrocardiogram or to a consultation with a cardiologist, and funduscopy. 838 type 2 diabetes 
patients in the intervention group were compared with those of 1018 type 2 diabetes patients in the 
controlled group (i.e. followed by standard GPs, without any nurse intervention in their practice). The 
ASALEE experiment is considered efficient if the proportion of patients that become or still be 
adequately followed-up over one year is greater than in the controlled group. We particularly look at 
the difference of impact between the two levels of nurse’s intervention within the ASALEE experiment.  
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We have used logistic regressions to model probabilities of becoming or still be followed correctly 
over one year for the six procedures (HbA1c, microalbuminuria, funduscopy, creatinemia, 
electrocardiogram, lipid check-up) and between the CG and the IG. For the patient in the latter we 
take in consideration whether or not the participants have had nurse visits for education and 
counselling. The results were controlled by: age (less than 49, from 50 to 59, from 60 to 69, from 70 to 
79, over 80), gender (female or male), location within the Deux-Sèvres department (north, south), 
type of Mandatory Social Security Funds (salaried employees, farmer workers), the presence or not of 
medicated treatments indicating lipid problems and/or diabetes complications, the type of medicine 
treatment for diabetes (one oral antidiabetic drug, the association of two oral antidiabetic drugs, the 
association of oral antidiabetic drug and insulin). 
The second efficacy evaluation was based on the analysis of the evolution over one year of the 
efficacy through final outcomes: the probabilities, before and after the intervention, of maintaining 
one’s glycosylated haemoglobin
3 (HbA1c) or reducing it to a level below or equal to three different 
thresholds: 6.5%, 7%, 8%. Measuring HbA1c before and after the intervention of the nurses was 
performed for 588 patients of the ASALEE experiment. The evolution of HbA1c was compared to that 
of a control group of 202 type 2 diabetes patients followed by a panel of standard GPs (with no nurses 
intervention in their practices)
4. The ASALEE experiment is considered efficient if the proportion of 
patients under glycemic control improve, over one year, greater than in the controlled group. We 
particularly look at the difference of impact between the two levels of nurse’s intervention within the 
ASALEE experiment. 
We used logistic regressions to model probabilities of maintaining or reducing HbA1c, before-and-
after the intervention, regarding the three different thresholds of glycemic control and between the CG 
and the IG. For the latter we take in consideration whether or not the patients have had nurse visits 
for education and counselling. The results were controlled by: age (under 65, over 65), gender 
(woman versus man), the HbA1c status (value at baseline, number of HbA1c tests performed in the 
year following inclusion, number of months separating the measurements before-and-after) and 
seasonality (waves of inclusion: June 2004 to March 2005, April 2005 to January 2006, February 
2006 to June 2006, July 2006 to May 2007). 
Finally, the cost evaluation concerns the analysis of the evolution between two consecutive years – 
between July 2005-June 2006 period (t-1) and between July 2006-June 2007 period (t) – of the type 2 
diabetes direct costs for National Health Insurance Funds both for the IG and for the CG. The costs 
analyses were based on claims data and we distinguished the total expenditure for all procedures – 
i.e. all the direct cost for type 2 diabetes patients (hospital and ambulatory care procedures where 
include) reimbursed by the National Health Insurance Funds – and total expenditure specific to type 2 
diabetes. These latter included all the direct costs allocated to diabetes by using the coding of medical 
procedures and services stemming from claims data: all the expenses of following up diabetes, 
including those related to the risk factors of diabetes (e.g. visits or treatment for smoking cessation) 
and its complications (e.g. treatment for ischemic cardiopathy). 
The evolution of theses costs were compared between the IG, 795 type 2 diabetes patients, and the 
CG, 956 type 2 diabetes patients followed by “standard” GPs (with no NURSES intervention in their 
practice). It should be noted first that the cost for ASALEE patients is increased by the expenses 
specific to the experiment (nurses’ salaries, training expenses, etc.), i.e. €60/yr per patient.  
We used a linear regression model in order to compute total and specific to diabetes costs in t 
according to the t-1 expenditures, between the IG and the CG and controlled by the following 
confounders: age (< 50 years old, 50-60 years old, 60-70 years old, 70-80 years old, > 80 years old), 
gender (woman or man), location within the department (north, south), type of Mandatory Social 
Security Scheme (salaried/employees or farmers people), the presence of treatment indicating lipid 
troubles and/or cardiovascular complications of diabetes (present or not), type of medicinal treatment 
                                                      
3  Glycosylated haemoglobin, glycated haemoglobin or more simply blood sugar provides the measurement of red blood 
cells fixing glucose in the haemoglobin of the organism. This concentration depends on cumulated variations of 
glycemia (rate of glucose in the blood) during the last 3-4 months. HbA1c expresses the glycemic control of a type 2 
diabetes patient. This is why it is recommended to dose it every three months. In a non-diabetic individual, less than 6% 
of haemoglobin is glycated. 
 
4  The panel was called General Medicine Observatory (Observatoire de la médecine générale – http://omg.sfmg.org ) of 
the French Society of general medicine (Société Française de Médecine Générale – http://www.sfmg.org/).  
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for diabetes (one oral antidiabetic drug, the association of two oral antidiabetic drugs, the association 
of oral antidiabetic drug and insulin), hospitalization (at least one hospitalization in t-1, at least one 




Descriptive statistics show that type 2 diabetes patients included in the experiment ASALEE   
are significantly better followed than other control patients, for all the process outcomes retained at 
the two consecutive periods , and that the improvement between the two periods is greater for them 
(Cf. Table 2). 
Table 2 - Descriptive statistics at baseline (t-1) and over one year (t) for efficacy according to 
process outcomes measures (follow-up procedures) between intervention and control groups 
 
Standard follow-up procedures 




























>= 3 examination of HbA1c 46.78 35.27 0.000 61.93 44.5 0.000 32.38 26.17
>=1 examination of creatinemia 79.95 75.34 0.009 91.53 81.53 0.000 14.48 8.22
>=1 examination microalbuminuria 49.4 17.78 0.000 64.56 21.71 0.000 30.69 22.10
>=1 examination lipid check-up 67.18 58.06 0.000 83.53 66.21 0.000 24.34 14.03
>=1 Electrocardiogram or visit with 
a cardiologist
24.94 21.51 0.040 46.54 27.21 0.000 86.61 26.50
>=1 funduscopy or or visit with an 
ophtalmologist 
40.43 36.27 0.060 43.21 37.54 0.018 6.88 3.50
Period (t-1) 
between July 2005-June 2006
Period (t)
between July 2006-June 2007
Variation rate




Logistics models confirm this fact (see Table 3) and we therefore observe, ceteris paribus, that a type 
2 diabetes patient followed up in the ASALEE experiment has, depending on procedures, 2.1 to 6.8 
times more chances than one followed-up by another “standard” GP of remaining or becoming well 
followed-up over one year (OR equals 2.1 for HbA1c to 6.8 for microalbuminuria tests). 
The fact that a type 2 diabetes patient within the IG benefits from a visit for education and counselling 
provided by nurses – 44% of patients were concerned – does not increase dramatically these odd-
ratios, even if they all increase except for carrying out creatinemia measurements (see Table 4). 
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Table 3 - Modelling of the efficacy according to process outcomes measures (follow-up 
procedures) 
 
Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value
Intervention or Control Groups
Controlled Group Ref. Ref. Ref. Ref. Ref. Ref.
ASALEE experiment 2.12 <.0001 6.816 <.0001 1.254 0.0462 2.534 <.0001 2.401 <.0001 2.617 <.0001
Age
< 50 years old 0.454 <.0001 0.693 0.0838 0.731 0.1661 0.48 0.0015 0.476 0.0013 0.704 0.0989
50-60 years old 0.686 0.0085 0.766 0.0887 1.003 0.9871 0.734 0.1046 0.84 0.2512 0.934 0.687
60-70 years old Ref. Ref. Ref. Ref. Ref. Ref.
70-80 years old 1.1 0.4501 0.937 0.6329 1.217 0.1836 1.479 0.0401 1.466 0.0032 0.879 0.3816
> 80 years old 1.286 0.1545 0.596 0.0081 0.995 0.9828 1.702 0.0607 1.069 0.7141 0.385 <.0001
Gender
Woman 1.034 0.7368 1.038 0.7281 1.341 0.0103 1.072 0.6194 0.765 0.0093 1.033 0.7691
Man Ref. Ref. Ref. Ref. Ref. Ref.
Localisation within the Deux-
Sèvres department
North Ref. Ref. Ref. Ref. Ref. Ref.
South 0.699 0.0012 0.765 0.0253 0.971 0.8147 1.015 0.9261 0.552 <.0001 0.87 0.2701
Type of Mandatory Social 
Security Scheme
General (salaried people) 0.826 0.0804 1.162 0.2111 - - 0.906 0.5368 1.152 0.2165 1.121 0.3461
Farmer (farmer people) Ref. Ref. - - Ref. Ref. Ref.
Presence of medicated diabetes 
complication
Yes 0.967 0.8568 0.914 0.6519 1.466 0.0859 1.54 0.0523 2.037 0.0014 1.945 0.0005
No Ref. Ref. Ref. Ref. Ref. Ref.
Type of medicine treatment
one oral antidiabetic drug 0.465 <.0001 0.598 <.0001 0.965 0.7891 0.623 0.004 0.739 0.0112 0.914 0.4789
association of two oral 
antidiabetic drugs
0.778 0.0497 0.814 0.1346 1.227 0.168 0.794 0.2263 0.877 0.3165 1.104 0.5007
association of oral antidiabetic 
drug and insulin
Ref. Ref. Ref. Ref. Ref. Ref.
Adjustment statistics
Deviance 436.76 <.0001 358.48 0.0228 182.19 0.3588 316.56 0.3414 330.53 0.1703 344.84 0.0675
Pearson 363.55 0.0146 307.75 0.4771 154.34 0.8789 315.36 0.359 289.12 0.7608 301.12 0.5839
Wald test 140.79 <.0001 336.38 <.0001 24.32 0.0068 85.99 <.0001 145.26 <.0001 111.26 <.0001
Pseudo R2 0.0610 0.1563 0.0141 0.0619 0.0682 0.0572
Percent Concordant 66.3 75.2 56.5 66.9 66.8 65.4
Somers' D 0.335 0.514 0.154 0.351 0.345 0.318
ROC curve 0.667 0.757 0.577 0.675 0.672 0.659
gamma 0.338 0.519 0.158 0.355 0.348 0.321
HbA1c Microalbuminuria Funduscopy Creatinemia ECG Lipid checkup
 
Ref.: modality of reference 
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Table 4 - Regression results for the logistic model of becoming or still be followed correctly 
over one year for six procedures between the ASALEE experiment and the controlled groups 
Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value
Intervention or Control Groups
Controlled Group Ref. Ref. Ref. Ref. Ref. Ref.
ASALEE experiment without 
nurses visits for patient 
education and counselling 1.868 <.0001 6.716 <.0001 1.207 0.1799 2.761 <.0001 2.547 <.0001 2.154 <.0001
ASALEE experiment withnurses 
visits for patient education and 
counselling 2.445 <.0001 6.926 <.0001 1.303 0.0597 2.324 <.0001 2.698 <.0001 2.7 <.0001
Age
< 50 years old 0.449 <.0001 0.692 0.0829 0.728 0.1622 0.482 0.0016 0.703 0.0974 0.472 0.0011
50-60 years old 0.681 0.0074 0.765 0.0878 1.001 0.9945 0.735 0.1074 0.934 0.683 0.835 0.2349
60-70 years old
70-80 years old 1.096 0.4677 0.936 0.6305 1.215 0.1885 1.481 0.0392 0.879 0.3794 1.461 0.0035
> 80 years old 1.295 0.1438 0.597 0.0083 0.997 0.9891 1.698 0.0619 0.385 <.0001 1.076 0.6878
Gender
Woman 1.02 0.8446 1.036 0.7425 1.337 0.0113 1.079 0.5901 1.031 0.7864 0.754 0.0065
Man
Localisation within the Deux-
Sèvres department
North
South 0.705 0.0017 0.767 0.0264 0.973 0.8324 1.01 0.9487 0.872 0.2789 0.557 <.0001
Type of Mandatory Social 
Security Scheme
General (salaried people) 0.821 0.0726 1.161 0.2136 - - 0.908 0.5454 1.12 0.3506 1.146 0.2334
Farmer (farmer people) Ref. Ref. - - Ref. Ref. Ref.
Presence of medicated diabetes 
complication
Yes 0.961 0.8291 0.913 0.649 1.464 0.0868 1.543 0.0512 1.943 0.0005 2.026 0.0015
No Ref. Ref. Ref. Ref. Ref. Ref.
Type of medicine treatment
one oral antidiabetic drug 0.467 <.0001 0.598 <.0001 0.967 0.8002 0.621 0.0039 0.914 0.4814 0.742 0.0123
association of two oral 
antidiabetic drugs
0.779 0.0507 0.814 0.1347 1.229 0.1651 0.793 0.2251 1.104 0.5004 0.877 0.3174
association of oral antidiabetic 
drug and insulin
Ref. Ref. Ref. Ref. Ref. Ref.
Adjustment statistics
Deviance 538.03 <.0001 464.40 0.011 270.90 0.0491 389.95 0.5902 431.40 0.113 468.17 0.0079
Pearson 444.41 0.0502 390.11 0.5879 224.44 0.6617 422.81 0.1787 385.04 0.6573 397.08 0.4895
Wald test 143.16 <.0001 336.42 <.0001 24.55 0.0171 86.21 <.0001 111.27 <.0001 147.27 <.0001
Pseudo R2 0.0623 0.1563 0.0143 0.0623 0.0572 0.0693
Percent Concordant 66.5 75.3 0.156 66.9 65.5 66.9
Somers' D 0.338 0.514 0.495 0.351 0.32 0.347
ROC curve 0.669 0.757 0.578 0.676 0.66 0.674
gamma 0.34 0.518 0.159 0.356 0.324 0.35
HbA1c Microalbuminuria Funduscopy Creatinemia ECG Lipid checkup
 
Ref.: modality of reference 
 
With respect to the evolution of HbA1c value over one year, descriptive statistics and t-test (see Table 
5) show that the type 2 diabetes patients enrolled in the ASALEE experiment, and who experienced a 
visit for education and counselling, had a statistically significant greater percentage point reduction in 
their HbA1c level (-0.34) than that of ASALEE patient without any nurses visits (-0.13) and of control 
group patients (-0.1).  
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Table 5 - Before and after descriptive statistics for efficacy according to the final outcome 
measure (glycemic control) for the ASALEE experiment and the controlled groups 
 
Control Group Control Group
No Yes Total No Yes Total
n 202 376 212 588
mean 7.36 7.08 7.29 7.16 2.58 0.55 1.91
std 1.33 1.06 1.24 1.13 (p<1%) (p>10%) (p<10%)
n 202 376 212 588
mean 7.26 6.95 6.95 6.95 3.11 2.68 3.25
std 1.21 1 1.14 1.05 (p<1%) (p<1%) (p<1%)
n 202 376 212 588
mean -0.1 -0.13 -0.34 -0.2 0.33 2.40 1.15
std 1.12 0.87 0.9 0.89 (p>10%) (p<5%) (ns)
HbA1c before
<= 6.5% n 58 127 65 192
% 28.71 33.78 30.66 32.65
[ 6.6%;8% ] n 96 198 91 289
% 47.52 52.66 42.92 49.15
> 8% n 48 51 56 107
% 23.76 13.56 26.42 18.2
HbA1c after
<= 6.5% n 67 154 89 243
% 33.17 40.96 41.98 41.33
[ 6.6%;8% ] n 89 173 99 272
% 44.06 46.01 46.7 46.26
> 8% n 46 49 24 73
% 22.77 13.03 11.32 12.41
Total n 202 376 212 588
% 100 100 100 100
0.7518 0.7855 <.0001 0.0004
Differences in means between ASALEE experiment and Control Group:





Before-and-After differences in proportions: Mac Nemar Test (p-value)
0.1797 0.0021 <.0001 <.0001
Descriptive statistics Non parametric Test
ASALEE experiment ASALEE experiment
Nurses visits for education and counselling Nurses visits for education and counselling
 
Notes: p value in bold are significant (p<10%) 
 
 
The specific effect of the level 2 nurse intervention on the improvement of the glycemic control, within 
the ASALEE experiment and compared to the control group, is confirmed by the results of logistic 
models (see Table 6). 
We observe that  the probability of maintaining one’s HbA1c or reducing it to 8% or less over one year 
is 1.8 times greater for the type 2 diabetes patients in the ASALEE group than for those in the control 
group (OR=1.8 for p<5%), ceteris paribus. Nevertheless, when seeking a more stringent judgement 
criterion,  i.e. when the HbA1c threshold chosen is 6.5% or 7%, no significant differences were 
observed between the two groups. 
That being said, when ASALEE patients are distinguished according to whether they were given at 
least one visit for education and counselling performed by nurses, there is a very significant 
improvement of glycemic control in the intervention group compared to the control group. We 
observed that the highest probability of having a HbA1c rate maintained at the same level or reduced 
to 8% or less over one year only significantly concerned patients who had had at least one 
therapeutic education (OR=2.7, p<1%). Moreover, the result is robust when applying a more stringent 
judgement criterion, i.e. an HbA1c threshold reduced to 6.5% or 7% (OR equal to 1.6 and 1.8 
respectively with p≤5%).  
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Table 6 - Regression results for the logistic model of maintaining or reducing HbA1c, before-
and-after the intervention, regarding the three different thresholds of glycemic control, 
between the ASALEE experiment and the controlled groups 
 
Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value Odds ratio p value
Intervention or Control Groups
Controlled Group Ref. Ref. Ref. Ref. Ref. Ref.
ASALEE experiment 1.335 0.1744 1.199 0.3747 1.753 0.0206
or
ASALEE experiment without patient 
education and counselling 
performed by PHN
1.152 0.5339 1.022 0.9223 1.368 0.2388
ASALEE experiement with patient 
education and counselling 
performed by PHN
1.803 0.0258 1.628 0.0572 2.673 0.0022
Age
< 65 years old 1.502 0.0349 1.178 0.389 0.924 0.742 1.538 0.0264 1.19 0.3599 0.899 0.6593
>= 65 years old Ref. Ref. Ref. Ref. Ref. Ref.
Gender
Woman 0.734 0.0907 0.988 0.9477 1.155 0.5319 0.713 0.0661 0.961 0.8243 1.12 0.6237
Man Ref. Ref. Ref. Ref. Ref. Ref.
Hba1c at baseline 0.19 <.0001 0.233 <.0001 0.375 <.0001 0.186 <.0001 0.227 <.0001 0.364 <.0001
Number of Hba1c realized 0.94 0.7525 1.13 0.5272 1.021 0.9342 0.903 0.6044 1.084 0.6786 0.969 0.9027
Number of months of follow up 0.946 0.2002 0.951 0.2362 0.901 0.0576 0.947 0.2091 0.953 0.2526 0.906 0.0716
Seasonality
06/2004 - 12/2004 Ref. Ref. Ref. Ref. Ref. Ref.
02/2005 - 07/2005 0.9 0.6508 1.189 0.4355 1.221 0.4719 1.018 0.9425 1.364 0.1832 1.418 0.2214
01/2006 - 06/2006 1.707 0.0155 1.876 0.0039 1.592 0.0951 1.861 0.006 2.055 0.0013 1.787 0.0427
Adjustment statistics
Deviance 715.87 0.8028 743.15 0.5534 506.06 1 720.42 0.826 752.86 0.5357 509.64 1
Pearson 3352.97 <.0001 1107.44 <.0001 646.47 0.9971 3941.26 <.0001 1185.25 <.0001 677.62 0.9821
Wald test 170.81 <.0001 168.79 <.0001 109.94 <.0001 171.50 <.0001 169.23 <.0001 110.53 <.0001
Pseudo R2 0.2974 0.2764 0.2236 0.3009 0.2803 0.2306
Percent Concordant 85.9 84.8 84.2 86,00 85,00 84.9
Somers' D 0.72 0.697 0.686 0.722 0.701 0.702
ROC curve 0.86 0.849 0.843 0.861 0.85 0.851
gamma 0.721 0.698 0.688 0.723 0.702 0.704
<= 6,5% <= 8%  <= 7%  <= 6,5% <= 7%  <= 8% 
 
Ref.: modality of reference 
 
We estimated for type 2 diabetes patients total direct cost (e.g. for all procedures) and total direct cost 
specific to type 2 diabetes (e.g. only for procedures regarding type 2 diabetes, its risk factors and 
complications) between two consecutive periods: between July 2005-June 2006 (t-1) and between 
July 2006-June 2007 (t). It appears that the costs of ASALEE patients are equivalent to those of the 
patients of the controlled group for the two periods. For the total cost, they are respectively around 
3.000 € in t and of 2.400 € in t-1.From the model we could conclude, ceteris paribus, in the absence 
of statistically significant difference in the progression of expenditure between patients followed up in 
ASALEE and patients of the control group. Finally, we have estimate the "theoretical" thresholds of 
additional cost from which we could consider that the differences in the progression of the expenditure 
would be significant between the ASALEE patients and those of the control group. From a step-by-
step modelling and on the basis of our samples, we estimate these thresholds at 640 € for the total 
cost and at 470 € for the cost attributable to the diabetes, to its risk factors or to the complications. 
  
Effect of a French Experiment of Team Work between General Practitioners and Nurses on Efficacy and Cost of Type 2 
Diabetes Patients Care 
Julien Mousquès, Yann Bourgueil, Philippe Le Fur, Engin Yilmaz              Irdes – January 2010 
- 12 -
Table 7 - Regression results for the linear regression of total costs and specific to diabetes 
costs in t according to the t-1 expenditures and between the ASALEE experiment and the 
controlled groups 
 
Coefficient p value Coefficient p value
Intercept 2092.24 <.0001 2083.64 <.0001
Intervention or Control Groups
Controlled Group Ref -R e f -
ASALEE experiment -81.28 0.465 -60.75 0.388
expenditures in t-1  0.48 <.0001 0.46 <.0001
Age
< 50 years old -504.82 0.026 -178.94 0.212
50-60 years old -111.73 0.496 22.5 0.829
60-70 years old Réf.-R é f.-
70-80 years old -65.78 0.65 102.99 0.261
> 80 years old 563.87 0.005 324.13 0.011
Gender
Woman -120.57 0.28 -106.51 0.132
Man Ref Ref
Localisation within the Deux-Sèvres department
Nord Ref Ref
Sud 184.18 0.142 163.81 0.039
Type of Mandatory Social Security Funds
General (salaried people) 57.62 0.644 -25.58 0.747
Farmer (farmer people) Ref Ref
Presence of medicated diabetes complication
Yes 684.6 0.002 287.73 0.04
No Ref Ref
The type of medicinal treatment for diabetes
one oral antidiabetic drug -1942.58 <.0001 -1920.74 <.0001
association of two oral antidiabetic drugs -1827.36 <.0001 -1749.99 <.0001
association of oral antidiabetic drug and insulin Ref Ref
Hospitalization
at least one hospitalization in t-1 -1350.82 <.0001 -517.71 <.0001
at least one hospitalization in t 3757.56 <.0001 1385.47 <.0001
at least one hospitalization in t and in t-1 2524.8 <.0001 927.66 <.0001
none Ref Ref
Adjustment statistics
R² 0.5153 - 0.4772 -
R² adjusted 0.5111 - 0.4727 -
Total costs in t Total cost in t specific to diabetes
  
Ref.: modality of reference 
 
4.  Discussion and conclusions 
 
The main purpose of this study was to provide some empirical evidence about the efficacy and the 
efficiency of the French team work experiment ASALEE – mixing GPs and nurses skills – regarding 
the management of type 2 diabetes patients. More specifically, following a general design of a 
controlled before–and–after study, some logistic and linear models were estimated to assess: first, the 
efficacy according to process (adequacy of follow-up procedures) and final outcomes (glycemic 
control); second, the differential impact between two levels of nurses intervention in complement to 
the GP (systematic electronic patient registry and electronic clinical reminder with or without patient 
education and counselling); third, the impact on direct cost including additional cost generated by the 
experiment.  
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With regard to the significant greater improvement, both of the follow-up adequacy and of the 
glycemic control, for the type 2 diabetes patients enrolled in the ASALEE experiment compared with 
those followed by “standard” GP practices, such an experiment could be considered as globally 
effective. In other words, the added value of teamwork between GPs and nurses is clearly 
demonstrated both for glycemic control (with the nurse visits for education and counselling) and 
process outcomes (with the nurse electronic patient registry and electronic GP reminder). 
The improvement of the adequacy with guidelines regarding process outcome indicators calls for 
some comments. Firstly, it should be noticed that the positive impact on process outcome 
improvement for the follow-up of diabetes patients is in line with the results of the only evaluation of a 
French health care network yet published in France [35]. It is also in line with a great number of 
literature reviews [2,8-12,22,37] with very similar design and method and for various quality 
improvement programs involving nurses (i.e. disease management, case management, team work or 
skill-mix experiment…). Secondly, in 2007, the level of adequacy with guidelines for process outcome 
in the ASALEE experiment were equivalent or not so far from those achieve in UK [37] and much 
greater than those observed by the French national survey on diabetes patients [28] for all the 
indicators except for carrying out eye examinations. 
The positive results regarding our final outcome, the improvement of the HbA1c rate and then of the 
proportion of patients be under glycemic control, were rather innovative because the studies that 
assess this type of outcomes were in a much more restricted number. It has been shown that the rate 
of Hba1c significantly decreased over one year in the ASALEE experiment with a points percentage 
reduction of 0.2 for all patients included and of 0.34 for patients who had experienced the nurses 
visits for education and counselling. Then we observed an increase in the proportion of diabetes 
patients under glycemic control over a year significantly greater than in the control group. 
This should be compared first to the secular trend affecting the HbA1c, and second to what it was 
observed in other studies. First, the experience of the UKPDS study demonstrated that the natural 
trend of HbA1c was to be worsened at a rate around 0.2% per year over a 10-year cohort observation 
period [38]. Second, the relative decrease in HbA1c here are consistent with the results of other 
studies with a very similar design and method and for various quality improvement programs: most of 
the studies observed a rather significant reduction of the Hba1c level, comprised between a 0.4 and a 
1.0 point percent reduction, and then an increase in the proportion of diabetes patients under 
glycemic control [36-44]. 
None of these studies concerned French experiments, and it is only recently that a disease 
management program lead by the National Health Insurance Fund for salaried people has been 
experimentally implemented for a targeted population of 140,000 diabetic patients. It is called 
SOPHIA and the results of its evaluation for final outcomes should not be available before mid-2010
5. 
A final set of results concerns the progression of costs over one year. These are not significantly 
higher in the ASALEE experiment than in the control group even if we take into account the additional 
cost generated by the experiment (i.e. nurses’ wages,…): €60/yr per patient. These additional costs 
was estimated by ASALEE on the basis of its accounts and its own records of nurse working time 
dedicated to the follow-up of diabetes patients. They should be compared to the one estimated by the 
National Health Insurance Fund for employee for the SOPHIA experimental disease management on 
a routine basis: €120/yr per patient. Moreover, as has been shown by the sensitive analysis, this is 
still the truth even if we let up the hypotheses for the additional costs in the ASALEE experiment and if 
we reached them to a very high threshold (€640/yr per patient for the total cost and €470/yr per 
patient for the cost attributable to the follow-up or treatment of diabetes, its risk factors or its 
complications). 
It should be mentioned that expenditure over one year is less here than that estimated by the French 
National Health insurance Fund for types 1 and 2 diabetes patients in long-term disease [25,30]. This 
difference can mainly be explained by the fact that our sample is made up in the same way and that it 
is limited to patients covered by health insurance in the Deux-Sèvres department. It does not 
represent diabetic patients with complications leading to high expenses (e.g. diabetes patients under 
dialysis). Furthermore, it was not possible to take public hospital expenses fully into account. The 
                                                      
5   See for futher information: http://www.ameli.fr/professionnels-de-sante/medecins/vous-former-et-vous-informer/sophia-
un-service-pour-les-malades-chroniques.php ;http://www.apmnews.com/story.php?numero=188739  
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exhaustiveness of the collection is better in t than in t-1, explaining part of the increase in expenditure 
between the two periods. 
Nonetheless, our results are consistent with the results of existing studies in other countries in terms 
of cost progression, relatively moderate, on a short-term basis when a quality improvement program 
for chronic disease was implemented [13,14,40,45]. The progression is due to the fact that the costs 
saving are expected in long term schedule. The progression is moderate because marginal cost of the 
procedures that should be run in order to ensure a better follow-up are very low regarding the total 
expenditure of diabetes patient. 
Finally, the model of GP nurse cooperation developed within the ASALEE natural experiment can be 
considered as efficient. This evaluation contribute to the large national policy experiment of skill 
mixing which gives place to a series of works, namely a recent national recommendation by the 
French National Authority in Health (Haute Autorité de Santé, HAS) and the National Observatory of 
Health Professions (Observatoire National de la Démographie des Professionnels de Santé, ONDPS 
2008) in April 2008 (HAS 2008). The recommendation requested a number of reforms on the 
education and training of health professionals, provided a regulatory framework for developing 
cooperation and argued in favour of their necessity. At least in France the question remains to modify 
model of financing primary care organisations who are involved in such quality improvement 
organisational strategy for chronic disease case management directly implemented by professional 
compared with disease management program models led directly by the National Health Insurance 
Funds, like the Sophia experiment. 
Some limitations should be taken into account in our study. Firstly, there is no random selection of 
GPs, nurses and patients and then some selection bias could occur. Secondly, we have a case study 
design extended to a controlled before-and-after design only for the evaluation of the final outcome 
but not for the evaluation of process outcomes and cost. Nevertheless, for the latter, we are able to 
implement a clear controlled before-and-after design, but only for a subsample of type 2 diabetes 
patient within the ASALEE experiment, those who were included during the final wave of the 
experiment (respectively 382 and 356 patients). We have run these models and the results still are 
robust for these subsamples. Thirdly, our patient attrition rate – mainly due to a change of location or 
because of a death – was about 13%. Fourthly, the evaluation was restricted to a proportion of all the 
eligible ASALEE patients: 40% for the glycemic control, 47% for the process outcomes and 49% for 
the costs. Fifthly, we could not include in our analysis some important unavailable variables: clinical 
and socioeconomic status variables with a broader scope than for those available here (e.g. 
occupation, income, education); other final outcome (e.g. body mass index, microvascular and 
macrovascular complications, quality of life). Finally, the conclusions in terms of efficiency are not 
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Effect of a French Experiment of Team Work between General Practitioners and Nurses 
on Efficacy and Cost of Type 2 Diabetes Patients care
Julien Mousquès, Yann Bourgueil, Philippe Le Fur (Irdes, Prospere), Engin Yilmaz (Drees)
This study aims to assess the efficacy and the cost of a French team work experiment between nurses and 
GPs for the managing of type 2 diabetes patients.
Our study was based on a case control study design in which we compare the evolution of process (stan-
dard follow-up procedures) and final outcomes (glycemic control), and the evolution of cost. The study 
is realized between two consecutive periods between type 2 diabetes patients followed within the team 
work experiment (intervention group) or by “standard” GPs (controlled group).
After a 11 months of follow-up, we showed that patients in the intervention group, compared with those 
in the controlled group, have more chances to remain or to become: correctly followed-up (with OR 
comprise between 2.1 to 6.8, p<=5%) and under glycemic control (with OR comprise between 1.8 to 2.7, 
p<=5%). The latter result is obtained only when a visit for education and counselling has been delivered 
by a nurse in supplement to systematic electronic patient registry and electronic clinical GPs reminder. 
All these results are obtained without difference in costs between the intervention and the controlled 
group.
Finally, this experimentation of team working can be considered both effective and efficient. Our fin-
dings may have implications in the design of future larger primary care team work experiments to be 
launched by French health authorities.
L’impact d’une expérimentation française de travail en équipe, entre généralistes 
et infirmières, sur l’efficacité et les coûts du suivi des patients diabétiques de type 2
Julien Mousquès, Yann Bourgueil, Philippe Le Fur (Irdes, Prospere), Engin Yilmaz (Drees)
Cette étude a pour objectif d’évaluer l’efficacité et les coûts d’une expérimentation de travail en équipe 
entre des infirmières et des généralistes (l’expérimentation ASALEE), dans le cas de la prise en charge des 
patients souffrant de diabète de type 2.
Elle s’appuie sur un design cas/témoin dans lequel nous comparons l’évolution des résultats de soins en ter-
mes de processus  (procédures standards de suivi) et de résultat final (le contrôle glycémique), ainsi qu’en 
termes de coûts. Cette comparaison est réalisée entre deux périodes consécutives et entre des patients 
diabétiques de type 2 suivis dans l’expérimentation (le groupe d’intervention) ou dans le groupe témoin (le 
groupe contrôle).
Nous montrons qu’après onze mois de suivi, les patients ASALEE, comparés à ceux du groupe témoin, 
ont une plus grande probabilité de rester ou devenir bien suivis en termes d’indicateurs de processus (OR 
compris entre 2.1 à 6.8, p < 5 %), ainsi qu’en termes de contrôle glycémique (OR compris entre 1.8 à 2.7, 
p < 5 %). Ces derniers résultats sont obtenus uniquement lorsque les patients ont bénéficié d’au moins une 
consultation infirmière d’éducation et de conseils hygiéno-diététiques en complément du rôle classique 
des infirmières dans le cadre de l’expérimentation ASALEE, c’est-à-dire la mise à jour des dossiers médicaux 
informatisés avec l’inscription éventuelle de rappels informatiques à destination des généralistes.